Uh-oh! This study is no longer available.
Advanced Non-Small Cell Lung Cancer – Involuntary Weight Loss
PMG Research of McFarland Clinic
18 or older
A research study is evaluating an investigational medication for patients experiencing involuntary weight loss due to advanced non-small cell lung cancer.
This research study may be an option if you:
• Have a diagnosis of stage 3 or 4 unresectable non-small cell lung cancer
• Have ongoing problems with appetite/eating associated with cancer
• Have no reversible cause of reduced food intake (i.e. severe depression, GI disorders such as nausea, vomiting, diarrhea or constipation, and/or oral mucositis)
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related procedures and study medication or placebo at no cost.
Patient Commitment Duration
Approximately 6 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 10 clinic visits and 1 phone call